Regeneron Pharmaceuticals Inc. buy Snowman
Start price
07.12.23
/
50%
€777.50
Target price
07.12.24
€900.00
Performance (%)
-4.51%
End price
08.12.24
€742.40
Summary
This prediction ended on 08.12.24 with a price of €742.40. With a performance of -4.51%, the BUY prediction for Regeneron Pharmaceuticals Inc. by Snowman closed slightly in the red. Snowman has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -0.126% | -0.126% | 19.823% |
| iShares Core DAX® | -1.424% | 8.918% | 7.311% |
| iShares Nasdaq 100 | 3.274% | 16.275% | 36.651% |
| iShares Nikkei 225® | 1.745% | 16.239% | 46.602% |
| iShares S&P 500 | 1.447% | 10.913% | 27.166% |
Comments by Snowman for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Snowman gewählte maximale Laufzeit wurde überschritten